drugset / Trial / NCT05699720
Acute Exacerbation of COPD and Nebulized Magnesium Sulphate
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to determine the effect of Nebulized Magnesium Sulphate as an add-on therapy with conventional treatment on In-hospital outcome in patients having acute exacerbation of COPD.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 250 mg | Inhaled |